ID20915A - Cincin heterosiklis baru yang beranggotakan 5, pembuatannya, penggunaannya dan pembuatan bahan farmasi yang terdiri dari cincin heterosiklis baru tersebut - Google Patents

Cincin heterosiklis baru yang beranggotakan 5, pembuatannya, penggunaannya dan pembuatan bahan farmasi yang terdiri dari cincin heterosiklis baru tersebut

Info

Publication number: ID20915A
Authority: ID; Indonesia
Prior art keywords: production; new; heterosiclic; pharmacy; ring
Prior art date: 1997-09-23

Application number

IDP981265A

Other languages

English (en)

Inventor

Volkmar Dr Wehner

Hans Ulrich Dr Stilz

Wolfgang Dr Schmidt

Dirk Dr Deifge

Original Assignee

Hoechst Marion Roussel De Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-23

Filing date

1998-09-21

Publication date

1999-03-25

1998-09-21 Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh

1999-03-25 Publication of ID20915A publication Critical patent/ID20915A/id

Links

125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Crystallography & Structural Chemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)

IDP981265A 1997-09-23 1998-09-21 Cincin heterosiklis baru yang beranggotakan 5, pembuatannya, penggunaannya dan pembuatan bahan farmasi yang terdiri dari cincin heterosiklis baru tersebut ID20915A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19741873A DE19741873A1 (de)	1997-09-23	1997-09-23	Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate

Publications (1)

Publication Number	Publication Date
ID20915A true ID20915A (id)	1999-03-25

Family

ID=7843291

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDP981265A ID20915A (id)	1997-09-23	1998-09-21	Cincin heterosiklis baru yang beranggotakan 5, pembuatannya, penggunaannya dan pembuatan bahan farmasi yang terdiri dari cincin heterosiklis baru tersebut

Country Status (24)

Country	Link
US (1)	US6034238A (id)
EP (1)	EP0905139B1 (id)
JP (1)	JP4603104B2 (id)
KR (1)	KR19990030046A (id)
CN (1)	CN1216767A (id)
AT (1)	ATE421524T1 (id)
AU (1)	AU748579B2 (id)
BR (1)	BR9803969A (id)
CA (1)	CA2247735A1 (id)
CZ (1)	CZ303198A3 (id)
DE (2)	DE19741873A1 (id)
HR (1)	HRP980519A2 (id)
HU (1)	HUP9802143A3 (id)
ID (1)	ID20915A (id)
IL (1)	IL126278A0 (id)
MY (1)	MY134191A (id)
NO (1)	NO984414L (id)
NZ (1)	NZ331983A (id)
PL (1)	PL191149B1 (id)
RU (1)	RU2240326C2 (id)
SK (1)	SK129598A3 (id)
TR (1)	TR199801870A2 (id)
TW (1)	TW588051B (id)
ZA (1)	ZA988668B (id)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19647380A1 (de) *	1996-11-15	1998-05-20	Hoechst Ag	5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19741235A1 (de) *	1997-09-18	1999-03-25	Hoechst Marion Roussel De Gmbh	Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19821483A1 (de)	1998-05-14	1999-11-18	Hoechst Marion Roussel De Gmbh	Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19922462A1 (de) *	1999-05-17	2000-11-23	Aventis Pharma Gmbh	Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
YU41202A (sh)	1999-12-28	2005-03-15	Pfizer Products Inc.	Ne-peptidni inhibitori vezivanja za ćeliju zavisnog od vla-4 korisni pri tretiranju inflamatornih, autoimunih i respiratornih bolesti
DE10111877A1 (de)	2001-03-10	2002-09-12	Aventis Pharma Gmbh	Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10111876A1 (de) *	2001-03-10	2002-09-19	Aventis Pharma Gmbh	Bis(trifluormethyl)hydantoine als Zwischenprodukte für pharmazeutische Wirkstoffe
DE10137595A1 (de)	2001-08-01	2003-02-13	Aventis Pharma Gmbh	Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
US7053112B2 (en) *	2002-09-24	2006-05-30	Schering Aktiengesellschaft	Imidazolidinedione analogs useful as anticoagulants and antithrombotics
SG141430A1 (en)	2003-05-30	2008-04-28	Ranbaxy Lab Ltd	Substituted pyrrole derivatives and their use as hmg-co inhibitors
US7577605B2 (en) *	2004-08-04	2009-08-18	Bgc Partners, Inc.	System and method for managing trading using alert messages for outlying trading orders
BRPI0618379A2 (pt)	2005-11-08	2011-08-30	Ranbaxy Lab Ltd	processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
EP2467159A1 (en)	2009-08-20	2012-06-27	INSERM (Institut National de la Santé et de la Recherche Médicale)	Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
EP3722808B1 (en)	2010-10-25	2024-09-11	Biogen MA Inc.	Methods for determining differences in alpha-4 integrin activity by correlating differences in svcam and/or smadcam levels
JP2021066690A (ja) *	2019-10-24	2021-04-30	国立大学法人室蘭工業大学	オピオイドペプチド誘導体及びこれを含む医薬組成物
US20240301512A1 (en)	2021-01-29	2024-09-12	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods of assessing the risk of developing progressive multifocal leukoencephalopathy in patients treated with vla-4 antagonists

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE235866C (id) *
DE2937779A1 (de) *	1979-09-19	1981-04-09	Hoechst Ag, 6000 Frankfurt	Aminosaeurederivate und verfahren zu ihrer herstellung
DE3044236A1 (de) *	1980-11-25	1982-06-16	Hoechst Ag, 6000 Frankfurt	Aminosaeurederivate und verfahren zu ihrer herstellung
FR2487829A2 (fr) *	1979-12-07	1982-02-05	Science Union & Cie	Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2503155A2 (fr) *	1980-10-02	1982-10-08	Science Union & Cie	Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
US4350704A (en) *	1980-10-06	1982-09-21	Warner-Lambert Company	Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
DE3177130D1 (de) *	1980-08-30	1990-01-11	Hoechst Ag	Aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung.
US4344949A (en) *	1980-10-03	1982-08-17	Warner-Lambert Company	Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
LU88621I2 (fr) *	1980-10-23	1995-09-01	Schering Corp	Sandopril
US4374847A (en) *	1980-10-27	1983-02-22	Ciba-Geigy Corporation	1-Carboxyalkanoylindoline-2-carboxylic acids
DE3226768A1 (de) *	1981-11-05	1983-05-26	Hoechst Ag, 6230 Frankfurt	Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
NZ202903A (en) *	1981-12-29	1988-01-08	Hoechst Ag	1-- pe pyrrol-2-yl-carboxylic acid derivatives and pharmaceutical compositions
DE3210496A1 (de) *	1982-03-23	1983-10-06	Hoechst Ag	Neue derivate bicyclischer aminsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung
DE3211397A1 (de) *	1982-03-27	1983-11-10	Hoechst Ag, 6230 Frankfurt	Spiro (4.(3+n))-2-aza-3-carbonsaeure-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
DE3211676A1 (de) *	1982-03-30	1983-10-06	Hoechst Ag	Neue derivate von cycloalka (c) pyrrol-carbonsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue cycloalka (c) pyrrol-carbonsaeuren als zwischenstufen und verfahren zu deren herstellung
DE3227055A1 (de) *	1982-07-20	1984-01-26	Hoechst Ag, 6230 Frankfurt	Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung
EP0109925A1 (de) *	1982-09-30	1984-05-30	Ciba-Geigy Ag	Mikrobizide Imidazolidin-2,4-dion-Derivate
DE3242151A1 (de) *	1982-11-13	1984-05-17	Hoechst Ag, 6230 Frankfurt	Neue derivate tricyclischer aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung, sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung
DE3246503A1 (de) *	1982-12-16	1984-06-20	Hoechst Ag, 6230 Frankfurt	Derivate der cis, endo-2-azabicyclo-(5.3.0)-decan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung
DE3643012A1 (de) *	1986-12-17	1988-06-30	Hoechst Ag	2,3-disubstituierte isoxazolidine, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
DE3818850A1 (de) *	1988-06-03	1989-12-07	Hoechst Ag	Oligopeptide mit zyklischen prolin-analogen aminosaeuren
DE4009506A1 (de) *	1990-03-24	1991-09-26	Hoechst Ag	Hydantoinderivate
DE4126277A1 (de) *	1991-08-08	1993-02-11	Cassella Ag	Hydantoinderivate
RU2032672C1 (ru) *	1991-08-20	1995-04-10	Институт физико-органической химии и углехимии им.Л.М.Литвиненко АН Украины	1,3-бис-(2,3-диакрилоилоксипропил) -5,5-диметил-2,4-имидазолидиндион в качестве модификатора фотополимеризующихся акрилатных композиций
CA2127462C (en) *	1992-01-13	1999-03-23	Roy R. Lobb	Treatment for asthma
JPH07506566A (ja) *	1992-02-12	1995-07-20	バイオゲン　インコーポレイテッド	炎症性胃腸病の処置
DE4207254A1 (de) *	1992-03-07	1993-09-09	Cassella Ag	4-oxo-2-thioxoimidazolidin-derivate
DE4213634A1 (de) *	1992-04-24	1993-10-28	Cassella Ag	2,4-Dioxo-imidazolidin-Derivate
DE4224414A1 (de) *	1992-07-24	1994-01-27	Cassella Ag	Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung
DE4228717A1 (de) *	1992-08-28	1994-03-03	Cassella Ag	Imidazolidin-Derivate
EP0677060A1 (en) *	1993-01-08	1995-10-18	Tanabe Seiyaku Co., Ltd.	Peptide inhibitors of cell adhesion
SG44845A1 (en) *	1993-01-12	1997-12-19	Biogen Inc	Recombitant anti-vla4 antibody molecules
WO1994017828A2 (en) *	1993-02-09	1994-08-18	Biogen, Inc.	Treatment for insulin dependent diabetes
DE4308034A1 (de) *	1993-03-13	1994-09-15	Cassella Ag	Neue Heterocyclen, ihre Herstellung und ihre Verwendung
DE4427979A1 (de) *	1993-11-15	1996-02-15	Cassella Ag	Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
AU693143B2 (en) *	1993-12-06	1998-06-25	Cytel Corporation	CS-1 peptidomimetics, compositions and methods of using the same
DE69535133T2 (de) *	1994-01-25	2008-08-21	Elan Pharmaceuticals, Inc., San Francisco	Humanisierte antikörper gegen das leukozytenadhäsionsmolekül vla-4
AU2958195A (en) *	1994-06-29	1996-01-25	Texas Biotechnology Corporation	Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
US5811391A (en) *	1994-08-25	1998-09-22	Cytel Corporation	Cyclic CS-1 peptidomimetics, compositions and methods of using same
GB9524630D0 (en) *	1994-12-24	1996-01-31	Zeneca Ltd	Chemical compounds
US6306840B1 (en) *	1995-01-23	2001-10-23	Biogen, Inc.	Cell adhesion inhibitors
DE19515177A1 (de) *	1995-04-28	1996-10-31	Cassella Ag	Hydantoinderivate als Zwischenprodukte für pharmazeutische Wirkstoffe
US5612363A (en) *	1995-06-02	1997-03-18	Berlex Laboratories, Inc.	N,N-di(aryl) cyclic urea derivatives as anti-coagulants
US6248713B1 (en) *	1995-07-11	2001-06-19	Biogen, Inc.	Cell adhesion inhibitors
ATE212990T1 (de) *	1996-03-20	2002-02-15	Hoechst Ag	Inhibitoren der knochenresorption und vitronectinrezeptor-antagonisten
JP2000516596A (ja) *	1996-07-25	2000-12-12	バイオジェン，インコーポレイテッド	細胞接着インヒビター
DE19647382A1 (de) *	1996-11-15	1998-05-20	Hoechst Ag	Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19647381A1 (de) *	1996-11-15	1998-05-20	Hoechst Ag	Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19647380A1 (de) *	1996-11-15	1998-05-20	Hoechst Ag	5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
WO1998042656A1 (en) *	1997-03-21	1998-10-01	Cytel Corporation	Novel compounds
DE19741235A1 (de) *	1997-09-18	1999-03-25	Hoechst Marion Roussel De Gmbh	Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate

1997
- 1997-09-23 DE DE19741873A patent/DE19741873A1/de not_active Withdrawn
1998
- 1998-09-17 EP EP98117660A patent/EP0905139B1/de not_active Expired - Lifetime
- 1998-09-17 IL IL12627898A patent/IL126278A0/xx not_active IP Right Cessation
- 1998-09-17 AT AT98117660T patent/ATE421524T1/de not_active IP Right Cessation
- 1998-09-17 DE DE59814334T patent/DE59814334D1/de not_active Expired - Lifetime
- 1998-09-21 NZ NZ331983A patent/NZ331983A/en unknown
- 1998-09-21 CA CA002247735A patent/CA2247735A1/en not_active Abandoned
- 1998-09-21 CZ CZ983031A patent/CZ303198A3/cs unknown
- 1998-09-21 SK SK1295-98A patent/SK129598A3/sk unknown
- 1998-09-21 TR TR1998/01870A patent/TR199801870A2/xx unknown
- 1998-09-21 ID IDP981265A patent/ID20915A/id unknown
- 1998-09-21 MY MYPI98004339A patent/MY134191A/en unknown
- 1998-09-22 BR BR9803969-5A patent/BR9803969A/pt not_active Application Discontinuation
- 1998-09-22 JP JP26835298A patent/JP4603104B2/ja not_active Expired - Fee Related
- 1998-09-22 CN CN98119544A patent/CN1216767A/zh active Pending
- 1998-09-22 ZA ZA988668A patent/ZA988668B/xx unknown
- 1998-09-22 AU AU86148/98A patent/AU748579B2/en not_active Ceased
- 1998-09-22 RU RU98117626/04A patent/RU2240326C2/ru not_active IP Right Cessation
- 1998-09-22 NO NO984414A patent/NO984414L/no not_active Application Discontinuation
- 1998-09-22 HR HR19741873.2A patent/HRP980519A2/hr not_active Application Discontinuation
- 1998-09-23 PL PL328789A patent/PL191149B1/pl unknown
- 1998-09-23 HU HU9802143A patent/HUP9802143A3/hu unknown
- 1998-09-23 US US09/158,772 patent/US6034238A/en not_active Expired - Lifetime
- 1998-09-23 KR KR1019980039351A patent/KR19990030046A/ko not_active Ceased
- 1998-09-25 TW TW087115671A patent/TW588051B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE19741873A1 (de)	1999-03-25
ZA988668B (en)	1999-03-23
NZ331983A (en)	2000-02-28
US6034238A (en)	2000-03-07
IL126278A0 (en)	1999-05-09
JP4603104B2 (ja)	2010-12-22
ATE421524T1 (de)	2009-02-15
CA2247735A1 (en)	1999-03-23
EP0905139A3 (de)	2002-12-18
PL328789A1 (en)	1999-03-29
NO984414L (no)	1999-03-24
HUP9802143A2 (hu)	1999-06-28
HRP980519A2 (en)	1999-06-30
TR199801870A2 (xx)	1999-04-21
KR19990030046A (ko)	1999-04-26
HU9802143D0 (en)	1998-11-30
AU8614898A (en)	1999-04-15
PL191149B1 (pl)	2006-03-31
NO984414D0 (no)	1998-09-22
BR9803969A (pt)	2000-05-02
CZ303198A3 (cs)	1999-04-14
AU748579B2 (en)	2002-06-06
DE59814334D1 (de)	2009-03-12
JPH11180960A (ja)	1999-07-06
EP0905139B1 (de)	2009-01-21
TW588051B (en)	2004-05-21
SK129598A3 (en)	1999-04-13
RU2240326C2 (ru)	2004-11-20
EP0905139A2 (de)	1999-03-31
MY134191A (en)	2007-11-30
CN1216767A (zh)	1999-05-19
HUP9802143A3 (en)	1999-11-29

Publication	Publication Date	Title
AR038429A2 (es)	2005-01-12	Compuestos 15-alquil-16-hidroxilo de marcfortina
MA25567A1 (fr)	2002-10-01	Nouvelle composition et son utilisation
NO890075L (no)	1989-07-10	Fremgangsmaate for fremstilling av terapeutisk aktive imidazoler.
ID25516A (id)	2000-10-05	Senyawa-senyawa yang mengandung cincin-cincin beranggotakan enam, proses pembuatannya, dan penggunaannya sebagai obat
EP0693282A3 (en)	1996-12-18	Bowel-soluble pellets containing duloxetine
ATE248824T1 (de)	2003-09-15	Substituierte phenylderivate, ihre herstellung und verwendung
MY123193A (en)	2006-05-31	Novel 2-(iminomethyl)amino-phenyl derivatives,preparation,application as medicines and compositions containing same
NO952207D0 (no)	1995-06-02	Anvendelse av 2-amino-6-A-propylamino-4,5,6,7-tetrahydrobenzotiazol (pramipexol) som et antidepresivt legemiddel
ES2107284T3 (es)	1997-11-16	Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
HU9802143D0 (en)	1998-11-30	New heterocyclic compounds of 5 members in the ring, process for producing them and pharmaceutical compositions containing them
EA200000023A1 (ru)	2000-08-28	Производные 2-(-4-арил или гетероарил-пиперазин-1-илметил) -1h-индола
FI901096A0 (fi)	1990-03-02	Menetelmä farmakologisesti aktiivisten /3-(C16-C18)alkaanisulfinyyli- ja -sulfonyyli-2-metoksimetyylipropyyli/-(2-trimetyyliammonio-etyyli)fosfaattien valmistamiseksi
FI971674A0 (fi)	1997-04-18	Heterosyklisen ryhmän sisältämät di-tert-butyyli-fenoliyhdisteet, käyttökelpoisia tulehduksenvastaisina aineina
ES2193539T3 (es)	2003-11-01	Benzonaftiridinas.
DK0747392T3 (da)	2001-01-29	Dobbeltvirkende inhibitorer indeholdende 1,2-diazepiner
CZ282732B6 (cs)	1997-09-17	Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
EP0604354A3 (en)	1995-02-08	Antidepressant and anti-Parkinson's disease compounds.
ES2152379T3 (es)	2001-02-01	Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
TR199802044T2 (xx)	1999-02-22	Yeni karbon asidi t�revleri, �retilmeleri ve kullan�mlar�.
ES2111871T3 (es)	1998-03-16	Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ATE228110T1 (de)	2002-12-15	Cyclopentenon-derivate
ID19931A (id)	1998-08-27	Senyawa cincin 7-anggota terfusi tersubstitusi sulfonamida, penggunaannya sebagai obat-obatan, dan pembuatan sediaan farmasi yang mengandung senyawa tersebut
NO934758L (no)	1994-06-24	Alkylsubstituerte heterosykliske forbindelser
NO961168L (no)	1996-05-23	Nye uretanholdige aminosteroid forbindelser
BR0012622A (pt)	2002-06-11	Derivados de 3-amino-2-benzil-1-fenil-propano